#cardiovascular

Collection of cardiovascular news, found 182 news.

Resverlogix's BET Protein Inhibitor RVX-208 Meets Primary Endpoint

Resverlogix Corp. (TSX: RVX) today announced that the BET protein inhibitor RVX-208 significantly increased HDL-C ...

Global Hypertension Experts Launch First-of-its-Kind Online Resource

- The Power Over Pressure steering committee today announced the launch of the world's first online resource created to ...

Takeda Officially Opens Development Center in China

- Takeda Global Research and Development Asia, Pte. Ltd. ("TGRD (Asia)") and Takeda Shanghai Development Center ...

MAQUET Cardiovascular Announces Acquisition of the Avalon Elite(R)

-                    ...

Largest Comparative Study of Radioembolisation Shows SIR-Spheres Microspheres Significantly Improves

-       - New Australian Data Provides Further Evidence of Survival Benefit for ...

Study: Daily diet soda may increase risk of heart attack, stroke

Diet soda may benefit the waistline, but people who drink it everyday may have a heightened risk of heart attack and ...

Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth

-         Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced ...

Pakistan president had "minor heart attack"

Pakistan President Asif Ali Zardari suffered a "minor heart attack" and has undergone an operation in Dubai, but is in ...

Impact of Early Insulin Initiation on Glycemic Control in Asian People with Type 2 Diabetes

-     Two studies presented at World Diabetes Congress 2011 provide further evidence of the ...

Eating more fish may cut young women`s heart disease risk

Young women may reduce their risk of developing cardiovascular disease simply by eating more fish rich in omega-3 ...

CAPRELSA(TM) (vandetanib) Receives Positive CHMP Opinion in the European Union

-         AstraZeneca today announced that the Marketing Authorisation Application ...

On World COPD Day, Patients are Urged to Take Extra Care Ahead of This Winter

-                 - Updated international ...

CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies

-             CMC Biologics today announced the execution of an ...

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

-            - Findings from Two-Year Pivotal Phase III TEMSO Trial ...

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

-    In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...